Pan-Cancer Analysis Pinpoints Targets in PI3K Pathway [News in Brief]

A new study of all 32 cancer types in The Cancer Genome Atlas identifies genomic alterations that increase the activity of the PI3K/AKT/mTOR pathway. The study, which combines mutation data with measures of protein levels and phosphorylation status, suggests that mutations in IDH1, VHL, and STK11 promote activation of the pathway and may point to new drug targets.
Source: Cancer Discovery - Category: Cancer & Oncology Tags: News in Brief Source Type: research